Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

A new compound may treat benign prostatic hyperplasia better than finasteride.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Human placental extract may help hair growth by affecting certain cell signals and could be more effective with minoxidil.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Blocking a protein called prostaglandin D2 might help treat hair loss.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

HMG-CoA reductase is crucial for skin wound healing by regulating keratinocyte growth and blood vessel formation.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

3-Hydroxypropionic acid may help treat hair loss by promoting hair growth in cells.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Drugs like PDEI may help hair disorders like AGA.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Certain alkaloids could help create new coronavirus drugs.

Some dibenzo compounds might help treat cancer with fewer side effects.

A mutation in the hHb3 gene is linked to the hair disorder monilethrix.